We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.

AusPAR: ChAdOx1-S

Australian Public Assessment Report

AusPAR

AusPAR: ChAdOx1-S - COVID-19 Vaccine AstraZeneca [PDF, 919.4 KB]

AusPAR: ChAdOx1-S - COVID-19 Vaccine AstraZeneca [Word, 1.68 MB]

Attachment: Product Information for ChAdOx1-S - COVID-19 Vaccine AstraZeneca [PDF, 225.05 KB]

Attachment: Product Information for ChAdOx1-S - COVID-19 Vaccine AstraZeneca [Word, 87.57 KB]

Device/Product Name

COVID-19 Vaccine AstraZeneca

Active ingredients

ChAdOx1-S

AusPAR Date

15 February 2021

Published

19 October 2021

Submission Number

PM 2020 06115 1-2

Submission Type

New biological entity

Decision

Approved for provisional registration